MNG update: Non-Emergency Medical Transportation
Integrated Point32Health Medical Necessity Guidelines for Non-Emergency Medical Transportation.
Integrated Point32Health Medical Necessity Guidelines for Non-Emergency Medical Transportation.
A standard authorization form for ABA services has been adopted.
Pharmacy coverage changes for various Point32Health products.
Reminder of our biosimilar strategy for trastuzumab oncology drugs.
The Individual Consideration Services Payment Policy is being updated effective June 1.
Massachusetts law now requires mandatory exceptions in step therapy protocols.
Annual mental health wellness exams covered at no cost for certain members.
Lead screenings for ages 0-6 years covered with no member cost share.
Pharmacy coverage changes for various Point32Health products.
We’re reminding providers of our comprehensive genomic profiling coverage and authorization process.
Use code A4287, not K1005, for coverage of breast milk storage bags.
Integrated Point32Health Ambulance and Transportation Services Payment Policy and reimbursement update.
Pharmacy coverage changes for various Point32Health products.
Monogram Health program includes Tufts Health Direct members as of Jan. 1.
Point32Health would like to offer some reminders pertaining to our Pharmacy program.
Pharmacy coverage changes for various Point32Health products.
Pharmacy coverage changes for various Point32Health products.
Coverage reminders related to our Pharmacy program.
Urine Drug Testing coverage and payment policy updates.
Expanding Monogram Health kidney disease program to Tufts Health Direct.
Effective Jan. 1, 2024, the following outpatient cost share updates will apply to Tufts Health Direct members:
HIV PrEP billing requirements and new ICD-10 code.
Jan. 1, 2024 Pharmacy coverage changes for various Point32Health products.
Preferred products for the bevacizumab, rituximab, and trastuzumab drug classes.
2024 Pharmacy updates: Harvard Pilgrim commercial, Tufts commercial, Tufts Health Direct.
Learn more about mandatory exceptions in step therapy protocols.
Point32Health would like to remind providers of our Synagis (palivizumab) policy for the 2023-2024 season.
When billing for HIV PrEP and other related services, please bill in accordance with our Harvard Pilgrim Patient Protection and Affordable Care Act (Federal Health Care Reform) policy and Tufts Health Plan Preventive Services Payment Policy.
Read more for information on updates to Point32Health’s Pharmacy prior authorization programs.
As a reminder, Harvard Pilgrim commercial members who are currently taking a long-acting opioid and who have not had a clinical review completed will require authorization on or after Nov. 1, 2023.
Read more for information on updates to Point32Health’s Pharmacy prior authorization programs.
Effective for fill dates on or after Jan. 1, 2024, Harvard Pilgrim Health Care Commercial Plans, Tufts Health Plan Commercial Plans and Tufts Health Plan Direct will only cover prescription generic prenatal vitamins on our pharmacy formulary.
Effective Oct. 1, 2023, the identified generic inhaler products will not be covered in the formularies for Harvard Pilgrim Health Care commercial, Tufts Health Plan commercial and Tufts Health Direct. Alternative NDCs for the same drug, and similar agents, are covered on our formularies.
As a reminder, Harvard Pilgrim commercial members who are currently taking a long-acting opioid and who have not had a clinical review completed will require authorization on or after Nov. 1, 2023.
AbleTo’s personalized therapy program is now available to Tufts Health Direct, Tufts Health Together-MCO, and Tufts Medicare Preferred members, and will continue to be offered to Harvard Pilgrim Health Care commercial and Stride (HMO/HMO-POS) Medicare Advantage members.
Effective immediately, any products listed on the Harvard Pilgrim Health Care commercial, Tufts Health Plan commercial, and Tufts Health Direct formularies that have not been approved by the FDA will be excluded from coverage, in alignment with the information listed on our Evidence of Coverage documents and Member Handbooks.
Read more for information on updates to Point32Health’s Pharmacy prior authorization programs.
Please be aware that for dates of service beginning Sept. 1, 2023, the readmission policies for DRG facilities for Tufts Health Direct, Tufts Health Together, and Tufts Health RITogether will be expanded to apply to providers reimbursed at a case rate.
As we announced in previous issues of Insights and Updates for Providers, Point32Health currently reimburses medical services provided via telehealth for our commercial Harvard Pilgrim Health Care and Tufts Health Plan members in Massachusetts, Rhode Island, and Maine at 80% of the in-person rate.
Review this chart for updated Pharmacy Medical Necessity Guidelines with changes effective August 1, 2023 for Point32Health’s Pharmacy drug prior authorization program.
Effective for dates of service beginning July 1, 2023, the medications identified in this article will no longer be offered through CVS Caremark as part of Tufts Health Plan’s office-administered medical drug/white bagging program.
Effective for dates of service beginning July 1, 2023, Point32Health will no longer provide reimbursement for claims submitted with modifiers TM and TR for services provided in conjunction with a student’s individualized education program.
We’re updating our Medical Necessity Guidelines for the behavioral health services Transcranial Magnetic Stimulation, Psychological Testing and Assessment, and Neuropsychological Testing and Assessment, effective for dates of service beginning July 1, 2023.